ApicHope Pharmaceutical Group Co (SZSE:300723) Net Income From Continuing Operations : ¥-609 Mil (TTM As of Mar. 2025)

View and export this data going back to 2017. Start your Free Trial

What is ApicHope Pharmaceutical Group Co Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. ApicHope Pharmaceutical Group Co's net income from continuing operations for the three months ended in Mar. 2025 was ¥53 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2025 was ¥-609 Mil.

ApicHope Pharmaceutical Group Co Net Income From Continuing Operations Historical Data

The historical data trend for ApicHope Pharmaceutical Group Co's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ApicHope Pharmaceutical Group Co Net Income From Continuing Operations Chart

ApicHope Pharmaceutical Group Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Income From Continuing Operations

Get a 7-Day Free Trial

223.64

293.42

262.10

151.80

-566.71

ApicHope Pharmaceutical Group Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Net Income From Continuing Operations	Get a 7-Day Free Trial															95.49	-64.45	-300.48	-297.26	53.45

ApicHope Pharmaceutical Group Co Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-609 Mil.

ApicHope Pharmaceutical Group Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ApicHope Pharmaceutical Group Co Ltd (SZSE:300723) » Definitions » Net Income From Continuing Operations

Traded in Other Exchanges

N/A

Address

No. 27, Huanyu 1st Road, 15-19th Floor, Yunrun Building, Guangzhou International Bio-Island, Huangpu District. Guangdong Province, Guangzhou, CHN, 510320

Website

http://www.gdyph.com

ApicHope Pharmaceutical Group Co Ltd is engaged in Research and Development: pharmaceuticals; transfer of pharmaceutical technology; import and export of goods and technology; and leasing of non-residential real estate.

Executives

Yang De Ming	Independent director
Zhang Ming Yuan	Secretary Dong
Zhang Ying Ying	Supervisors
Li Han Dong	Director
Ke Rui Yu	Supervisors
Zhang Hui Xing	Executives

ApicHope Pharmaceutical Group Co Headlines

No Headlines